|
|
|
|
|
|
|
|
|
|
Rv2043c More about Rv2043c on TBDB.org More about Rv2043c on TubercuList |
Display all mutations or select a bar from the histogram above to examine in greater detail |
| Rv2043c: Codons 100 to 104: 13 mutations (high confidence mutations are highlighted in yellow) | |||||||||||||||
| Primary reference | Polymorphism | Nucleotide position | Codon position | Amino acid | Time period | Origin | Molecular detection method | Gene coverage | Resistance pattern | MIC | Susceptibility testing method | R/Total isolates | R/S isolates with mutation | Additional mutations | High confidence support |
| Cheng SJ AAC 2000 | ins G | 301 | - | Frameshift | - | South korea | Sequencing | Whole gene | Z | >500 | Proportion method, BACTEC 460 | 59/59 | 1/0 | - | - |
| Hou L Epi Infect 2000 | ins A | 301 | - | Frameshift | 1996-1998 | China | PCR-SSCP | Whole gene | ZHRS | 900 | Proportion method, BACTEC 460 | 35/65 | 1/0 | - | - |
| Marttila HJ AAC 1999 | GCG/ACG | 304 | 102 | Ala/Thr | 1994-1997 | Russia | Sequencing | Whole gene | Z | - | BACTEC 460 | 36/44 | 1/0 | not tested | - |
| Marttila HJ AAC 1999 | GCG/GTG | 305 | 102 | Ala/Val | 1994-1997 | Russia | Sequencing | Whole gene | Z | - | BACTEC 460 | 36/44 | 2/0 | not tested | ![]() |
| Lemaitre N AAC 1999 | ins C | 306 | - | Frameshift | 1989 | France | Sequencing | Whole gene | ZHRES | 500-1500 | - | 19/35 | 1/0 | - | - |
| Mestdagh M AAC 1999 | TAC/CAC | 307 | 103 | Tyr/His | 1999 | Canada | Sequencing | Whole gene | Z | - | BACTEC 460 | 23/62 | 1/0 | - | - |
| Lee KW J Korean Med Sci 2001 | del TACAG | 307 | - | Frameshift | 2001 | South Korea | Sequencing | Whole gene | Z | - | PZase test with Wayne's method | 92/95 | 1/0 | - | - |
| Lee KW J Korean Med Sci 2001 | TAC/TCC | 308 | 103 | Tyr/Ser | 2001 | South korea | Sequencing | Whole gene | Z | - | PZase test with Wayne's method | 92/95 | 2/0 | - | - |
| Lemaitre N AAC 1999 | TAC/TGC | 308 | 103 | Tyr/Cys | 1994 | France | Sequencing | Whole gene | ZHRE | 1500 | - | - | 1/0 | - | - |
| Marttila HJ AAC 1999 | TAC/TAG | 309 | 103 | Tyr/STOP | 1994-1997 | Russia | Sequencing | Whole gene | Z | - | BACTEC 460 | 36/44 | 1/0 | not tested | ![]() |
| Morlock GP AAC 2000 | TAC/TAA | 309 | 103 | Tyr/STOP | 1999 | - | Sequencing | Whole gene | Z | 100 | Proportion method | 37/60 | 1/0 | - | - |
| Scorpio A AAC 1997 | del C | 312 | 104 | Frameshift | 1992-1995 | - | PCR-SSCP | Whole gene | Z | >900ug/ml | Pzase testing by Wayne's method | 46/46 | 1/0 | - | - |
| Hirano K TLD 1997 | AGC/AGG | 312 | 104 | Ser/Arg | 1997 | Yemen | Sequencing | Whole gene | ZHRSE | >800 | Middlebrook 7H11 agar w/ pH of 6.0 | 33/168 | 1/0 | - | ![]() |
Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations. |
|
© 2010 Andreas Sandgren | Supported by the Swedish Research Council | Contact Database Curator |